Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
Clinical Nuclear Medicine|December 5, 2013
Three-phase bone scintigraphy for imaging osteoradionecrosis of the jawConstantin Lapa, Christian Linz, Christina Bluemel, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 18, 2016
Fusion of freehand SPECT and ultrasound: First experience in preoperative localization of sentinel lymph nodesChristina Bluemel, Gonca Safak, Andreas Cramer, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 9, 2017
PSMA Ligands for PET Imaging of Prostate CancerSarah M Schwarzenboeck, Isabel Rauscher, Christina Bluemel, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2010
Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancerJonas Schreyögg, Julia Weller, Tom Stargardt, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2014
Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trialFrancesco Ceci, Ken Herrmann, Paolo Castellucci, et al.Oncotarget|June 4, 2016
The impact of 177Lu-octreotide therapy on 99mTc-MAG3 clearance is not predictive for late nephropathyRudolf A Werner, Seval Beykan, Takahiro Higuchi, et al.Clinical Nuclear Medicine|February 3, 2015
SPECT- and PET-based patient-tailored treatment in neuroendocrine tumors: a comprehensive multidisciplinary team approachR A Werner, Christina Bluemel, M Lassmann, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2021
Novel CYP11B-ligand [<sup>123/131</sup>I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experienceBritta Heinze, Andreas Schirbel, Lukas Nannen, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 9, 2015
iROLL: does 3-D radioguided occult lesion localization improve surgical management in early-stage breast cancer?Christina Bluemel, Andreas Cramer, Christoph Grossmann, et al.EJNMMI Research|October 28, 2016
Impact of <sup>68</sup>Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomyChristina Bluemel, Fraenze Linke, Ken Herrmann, et al.Pageof 5